# RIFAMPIN
> **ANDA206736** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON PHARMS TEVA · Approved 2016-01-19
## Drug
- **FDA Application Number:** ANDA206736
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAMPIN
- **Generic name:** Rifampin
- **Active ingredients:** RIFAMPIN
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** WATSON PHARMS TEVA
- **First approval:** 2016-01-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206736)
---
*AI Analytics · CC0 1.0*